Skip to main content
Clinical Trials/NCT01139983
NCT01139983
Completed
Not Applicable

Search for Novel Genes in Osteosarcoma Revealed by Analysis of Tumour Copy-Number Alterations and Constitutional Copy-Number Variations

Children's Oncology Group0 sites90 target enrollmentApril 2010
ConditionsSarcoma

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Sarcoma
Sponsor
Children's Oncology Group
Enrollment
90
Primary Endpoint
Role of copy-number alterations (CNAs) in the etiology of osteosarcoma
Status
Completed
Last Updated
9 years ago

Overview

Brief Summary

RATIONALE: Studying samples of blood and tissue from patients with cancer in the laboratory may help doctors learn more about changes that occur in DNA and identify biomarkers related to cancer.

PURPOSE: This research study is studying DNA biomarkers in samples from patients with osteosarcoma and healthy volunteers.

Detailed Description

OBJECTIVES: * To determine whether common copy-number alterations (CNAs) at chr7p14.1 arise de novo in osteosarcoma (OS) tumor DNA or whether they represent progression of constitutional copy-number variations (CNVs). * To determine the association between constitutional CNVs at chr7p14.1 and susceptibility to OS. * To determine how CNVs translate into CNAs in tumor DNA samples from patients with OS. OUTLINE: RNA and DNA samples from banked blood and paired tumor tissue, plus samples from healthy controls, are analyzed for common copy-number alterations and constitutional copy-number variations (CNVs) at chr7p14.1 by microarray, q-PCR, RT-PCR, and FISH. Osteosarcoma predisposing CNVs results are then compared among cases versus healthy controls. Clinical information associated with each osteosarcoma sample (i.e., gender, age of diagnosis, tumor site, tumor type and grade, presence of metastases at time of diagnosis, response to chemotherapy, event-free survival, and overall survival) is also collected, if available. PROJECTED ACCRUAL: A total of 243 samples from patients with osteosarcoma and 80 samples from healthy controls will be accrued to this study.

Registry
clinicaltrials.gov
Start Date
April 2010
End Date
May 2016
Last Updated
9 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Role of copy-number alterations (CNAs) in the etiology of osteosarcoma

Association between copy-number variations (CNVs) at chr7p14.1 and susceptibility to osteosarcoma

Relationship between CNVs and tumor CNAs in osteosarcoma

Similar Trials